BRESLIN

BRESLIN is an investment and advisory firm based in Switzerland, providing customized solutions for small to large-cap global companies and investors in Life Sciences industries... BRESLIN was formed in 1999 as a private equity investment group for Life Sciences, mandated by Dresdner-Allianz Group, a German bank and insurance leader. Together with a team of specialists, BRESLIN sourced, managed, and successfully exited a Biotech portfolio that was syndicated with Deutsche Bank and Commerzbank. In 2004, BRESLIN became a European pioneer in the execution of private equity secondary transactions. Since 2005, BRESLIN has been providing financial and corporate development services to the Life Sciences industry... Based on long-standing expertise and an extensive network within the Biotech and Pharma industries, BRESLIN provides valuable opportunities to its clients for business development, cooperation, in and out licensing, and assistance in strategic or operational processes.

Also known as: Breslin AG, BRESLIN BIOTECH AG

Primary location: Zürich Switzerland